These findings are consistent with the pathological features of vitiligo KCs and may explain the decreased cancer risk of vitiligo KCs (73) because WNT/β-catenin signaling is downregulated (58, 59, 67, 68, 70, 71) and KCs damaged by oxidative stress are easily cleared from vitiligo lesions. The gene discussed is TBCE; the disease is cancer.